Surepharm - Chiltern Capital

The Business

Surepharm provides outsourced formulation, development, manufacturing and packaging of pharmaceutical products for its customers in the UK and overseas. Surepharm currently specialises in producing solid dose tablets and capsules, including niche medicines, controlled drugs and veterinary products.

The Deal

Chiltern Capital invested in 2022, acquiring the majority stake in the business, supporting the incoming Chair and management team to deliver the ambitious business plan.

“Surepharm has been a trusted supplier of pharmaceutical products and services to its customers for many years. With the support of Chiltern, we will be able to expand both the capacity and capabilities of the company to enhance our offering and to drive faster growth. It’s a very exciting time to be joining the company.”

Richard Yarwood, Chair

The Plan

Chiltern’s investment, and the introduction of a sector expert management team, will support Surepharm to enhance its formulation and development offering, as well as providing funding for capex investment into new dosage forms. Together with investment in the sales and marketing function, this will enable Surepharm to provide both existing and new customers with an end-to-end service, from drug development through to a packaged commercial product across a broad range of product types.

The Team

Joe Bennett

Investment Director

Harry Reid

Investment Associate

Back to Team

Joe Bennet

Joe is responsible for leading transactions and working with portfolio companies in the business services and industrials sectors. He has managed Chiltern’s investments into Assembuild, Surepharm, Intec and Batt Cables, and oversaw the successful exit of I Heart Studios.

Joe was previously a Director at a private family office, where he led European lower-mid market deals across a variety of sectors. He started his career at KPMG where he qualified as a Chartered Accountant in TMT Audit, before spending three years in the mid-market Transaction Services department.

Outside of work, Joe is kept busy by his young family and two rescue dogs. When time permits, he also enjoys getting out on the golf course and playing hockey for his local club.

Back to Team

Harry Reid

Harry joined Chiltern after several years advising local and global mid-market private equity firms. Harry is qualified as a Chartered Accountant.

Harry is involved in the assessment of new investment opportunities and supporting investee companies as a board member. He was involved in the investment into Rapid Repair Network and Strata Products and sits on the board of Inciner8.

Away from the office, Harry has a keen interest in rugby league and union, cricket and golf. He also enjoys travelling and talking all things agriculture, as he remains closely linked to family farming operations in rural Australia.